129 related articles for article (PubMed ID: 3560164)
1. Synthesis and binding affinities of analogues of cholecystokinin-(30-33) as probes for central nervous system cholecystokinin receptors.
Horwell DC; Beeby A; Clark CR; Hughes J
J Med Chem; 1987 Apr; 30(4):729-32. PubMed ID: 3560164
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
[TBL] [Abstract][Full Text] [Related]
3. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
Corringer PJ; Weng JH; Ducos B; Durieux C; Boudeau P; Bohme A; Roques BP
J Med Chem; 1993 Jan; 36(1):166-72. PubMed ID: 8421283
[TBL] [Abstract][Full Text] [Related]
4. Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptors.
Shiosaki K; Lin CW; Kopecka H; Bianchi B; Miller T; Stashko M; Witte D
J Med Chem; 1997 Mar; 40(7):1169-72. PubMed ID: 9089338
[TBL] [Abstract][Full Text] [Related]
5. Cyclic cholecystokinin analogues with high selectivity for central receptors.
Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of pseudo-peptide analogues of the C-terminal tetrapeptide of gastrin and evaluation of their biological activity on acid secretion.
Rodriguez M; Bali JP; Magous R; Castro B; Martinez J
Int J Pept Protein Res; 1986 Mar; 27(3):293-9. PubMed ID: 3011690
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
9. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP
J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834
[TBL] [Abstract][Full Text] [Related]
10. Conformational analysis of possible biologically active (receptor-bound) conformations of peptides derived from cholecystokinin, cerulein and little gastrin and the opiate peptide, Met-enkephalin.
Pincus MR; Murphy RB; Carty RP; Chen J; Shah D; Scheraga HA
Peptides; 1988; 9 Suppl 1():145-52. PubMed ID: 2856638
[TBL] [Abstract][Full Text] [Related]
11. CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue.
Bennett MJ; Nikkel AL; Bianchi BR; Miller TR; Bednarz L; Witte DG; Stashko M; Wang SS; Gore PA; Asin KE
J Med Chem; 1994 May; 37(11):1569-71. PubMed ID: 8201591
[TBL] [Abstract][Full Text] [Related]
12. Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.
Low CM; Black JW; Broughton HB; Buck IM; Davies JM; Dunstone DJ; Hull RA; Kalindjian SB; McDonald IM; Pether MJ; Shankley NP; Steel KI
J Med Chem; 2000 Sep; 43(19):3505-17. PubMed ID: 11000005
[TBL] [Abstract][Full Text] [Related]
13. CCK-8-related C-terminal tetrapeptides: affinities for central CCKB and peripheral CCKA receptors.
Harhammer R; Schäfer U; Henklein P; Ott T; Repke H
Eur J Pharmacol; 1991 Dec; 209(3):263-6. PubMed ID: 1797567
[TBL] [Abstract][Full Text] [Related]
14. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
Weng JH; Blommaert AG; Moizo L; Bado A; Ducos B; Böhme A; Garbay C; Roques BP
Bioorg Med Chem; 1996 Apr; 4(4):563-73. PubMed ID: 8735845
[TBL] [Abstract][Full Text] [Related]
15. [Conformational-functional relationships of tetragastrin analogs].
Nikiforovich GV; Liepinia IT; Tseĭtin VM; Shenderovich MD; Galaktionov SG
Bioorg Khim; 1991 May; 17(5):626-36. PubMed ID: 1768290
[TBL] [Abstract][Full Text] [Related]
16. Degradation of a tetragastrin analogue by a membrane fraction from rat gastric mucosa.
Dubreuil P; Lignon MF; Magous R; Rodriguez M; Bali JP; Martinez J
Drug Des Deliv; 1987 Sep; 2(1):49-54. PubMed ID: 3509344
[TBL] [Abstract][Full Text] [Related]
17. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
[TBL] [Abstract][Full Text] [Related]
19. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
20. Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.
Dezube M; Sugg EE; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; James MK; Johnson MF; Mosher JT
J Med Chem; 1995 Aug; 38(17):3384-90. PubMed ID: 7650691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]